Goldman Sachs' Stephen Tanal trimmed his target almost 5% to $291 citing, among other considerations, "fear of policy proposals."
JPMorgan's Gary Taylor cut his target almost 22% to $235 citing the same political risk, especially with single-payer approaches espoused by certain Democratic presidential candidates.
Stephens' Scott Fidel is also on the bandwagon, dropping his target 8% to $270.
Now read: Why UnitedHealth Is Due For A Rebound »
Subscribe for full text news in your inbox